Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $86 at RBC Capital Ahead of ESMO Conference

September 18, 2020 6:48 AM
RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $86.00 (from $82.00) after the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change